Une approche radio-chirurgicale cohérente, basée sur le PSA, pour la prise en charge du cancer de la prostate.

Translated title of the contribution: A coherent radiotherapeutic-surgical approach, based on PSA, for the management of cancer of the prostate

A. R. Kagan, P. E. Zimmern, B. Hintz, K. K. Himsl

Research output: Contribution to journalArticle

Abstract

The presence of cancer of the prostate does not mean that a patient will succumb to the disease. In fact, prior to the advent of prostate-specific antigen (PSA) testing, the cause of death in 50% of men with detectable extraglandular cancer was intercurrent disease. No studies have conclusively demonstrated a definitive benefit of surgery or radiation over simple observation; therefore treatment complications must absolutely be restricted to a bare minimum while demonstrating curative effect. This review presents a balanced perspective on the management of prostate cancer which results from non-adversarial, extensive, and continuous interactions between two very active Departments (Urology and Radiation Oncology). Such a multidisciplinary approach fosters relevant research projects and ultimately benefits patient care.

Original languageFrench
Pages (from-to)173-184
Number of pages12
JournalJournal d'Urologie
Volume100
Issue number4
StatePublished - 1994

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Radiation Oncology
Urology
Cause of Death
Patient Care
Observation
Radiation
Research
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Une approche radio-chirurgicale cohérente, basée sur le PSA, pour la prise en charge du cancer de la prostate. / Kagan, A. R.; Zimmern, P. E.; Hintz, B.; Himsl, K. K.

In: Journal d'Urologie, Vol. 100, No. 4, 1994, p. 173-184.

Research output: Contribution to journalArticle

@article{7467897239b04a49989f2f2333718d1e,
title = "Une approche radio-chirurgicale coh{\'e}rente, bas{\'e}e sur le PSA, pour la prise en charge du cancer de la prostate.",
abstract = "The presence of cancer of the prostate does not mean that a patient will succumb to the disease. In fact, prior to the advent of prostate-specific antigen (PSA) testing, the cause of death in 50{\%} of men with detectable extraglandular cancer was intercurrent disease. No studies have conclusively demonstrated a definitive benefit of surgery or radiation over simple observation; therefore treatment complications must absolutely be restricted to a bare minimum while demonstrating curative effect. This review presents a balanced perspective on the management of prostate cancer which results from non-adversarial, extensive, and continuous interactions between two very active Departments (Urology and Radiation Oncology). Such a multidisciplinary approach fosters relevant research projects and ultimately benefits patient care.",
author = "Kagan, {A. R.} and Zimmern, {P. E.} and B. Hintz and Himsl, {K. K.}",
year = "1994",
language = "French",
volume = "100",
pages = "173--184",
journal = "Journal d'Urologie",
issn = "0248-0018",
publisher = "Masson Publishing",
number = "4",

}

TY - JOUR

T1 - Une approche radio-chirurgicale cohérente, basée sur le PSA, pour la prise en charge du cancer de la prostate.

AU - Kagan, A. R.

AU - Zimmern, P. E.

AU - Hintz, B.

AU - Himsl, K. K.

PY - 1994

Y1 - 1994

N2 - The presence of cancer of the prostate does not mean that a patient will succumb to the disease. In fact, prior to the advent of prostate-specific antigen (PSA) testing, the cause of death in 50% of men with detectable extraglandular cancer was intercurrent disease. No studies have conclusively demonstrated a definitive benefit of surgery or radiation over simple observation; therefore treatment complications must absolutely be restricted to a bare minimum while demonstrating curative effect. This review presents a balanced perspective on the management of prostate cancer which results from non-adversarial, extensive, and continuous interactions between two very active Departments (Urology and Radiation Oncology). Such a multidisciplinary approach fosters relevant research projects and ultimately benefits patient care.

AB - The presence of cancer of the prostate does not mean that a patient will succumb to the disease. In fact, prior to the advent of prostate-specific antigen (PSA) testing, the cause of death in 50% of men with detectable extraglandular cancer was intercurrent disease. No studies have conclusively demonstrated a definitive benefit of surgery or radiation over simple observation; therefore treatment complications must absolutely be restricted to a bare minimum while demonstrating curative effect. This review presents a balanced perspective on the management of prostate cancer which results from non-adversarial, extensive, and continuous interactions between two very active Departments (Urology and Radiation Oncology). Such a multidisciplinary approach fosters relevant research projects and ultimately benefits patient care.

UR - http://www.scopus.com/inward/record.url?scp=0027973908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027973908&partnerID=8YFLogxK

M3 - Article

C2 - 7532672

AN - SCOPUS:0027973908

VL - 100

SP - 173

EP - 184

JO - Journal d'Urologie

JF - Journal d'Urologie

SN - 0248-0018

IS - 4

ER -